AngioDynamics, Inc. (ANGO) Stock

Healthcare · Medical Instruments & Supplies · Member of Other US Stocks

AngioDynamics, Inc. (ANGO) closed at USD 11.05 on 2026-10-14, a change of -10.1 % over the past year, with a market capitalization of USD 486.99M.

AngioDynamics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

AngioDynamics, Inc. key figures

Previous close

USD 11.05 (2026-10-14)

1-year change

-10.1 %

Market cap

USD 486.99M

Enterprise value

USD 463.76M

P/E ratio (trailing)

-14.85

P/E ratio (forward)

-102.18

EPS (trailing)

-0.78

EPS (forward)

-0.11

PEG ratio

1.41

Price to book

3.00

Revenue growth

6.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.65

Employees

632

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About AngioDynamics, Inc.

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for AngioDynamics, Inc. and compare it with other stocks.